Kish, Stephen J.

Brain cytochrome oxidase in Alzheimer's disease

Kish, S. J., Bergeron, C., Rajput, A., Dozic, S., Mastrogiacomo, F., Chang, L., Wilson, J. M., DiStefano, L. M., & Nobrega, J. N. (1992) · Journal of Neurochemistry

Alzheimer's disease research and treatmentsMitochondrial Function and Pathology

Cited by 537

In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [11C]-(+)-PHNO

Boileau, I., Payer, D., Chugani, B., Lobo, D. S. S., Houle, S., Wilson, A. A., Warsh, J., Kish, S. J., & Zack, M. (2014) · Molecular Psychiatry

Gambling Behavior and TreatmentsNeurotransmitter Receptor Influence on Behavior

Cited by 198

The D2/3dopamine receptor in pathological gambling: a positron emission tomography study with [11C]‐(+)‐propyl‐hexahydro‐naphtho‐oxazin and [11C]raclopride

Boileau, I., Payer, D., Chugani, B., Lobo, D., Behzadi, A., Rusjan, P. M., Houle, S., Wilson, A. A., Warsh, J., Kish, S. J., et al. (2013) · Addiction

Gambling Behavior and TreatmentsNeurotransmitter Receptor Influence on Behavior

Cited by 190

Regional distribution of serotonin transporter protein in postmortem human brain

Kish, S. J., Furukawa, Y., Chang, L.-J., Tong, J., Ginovart, N., Wilson, A., Houle, S., & Meyer, J. H. (2005) · Nuclear Medicine and Biology

Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

Cited by 179

Methamphetamine use and schizophrenia: A population-based cohort study in California

Callaghan, R. C., Cunningham, J. K., Allebeck, P., Arenovich, T., Sajeev, G., Remington, G., Boileau, I., & Kish, S. J. (2012) · American Journal of Psychiatry

Schizophrenia research and treatmentSubstance Abuse Treatment and Outcomes

Cited by 150

Mitochondria in Alzheimer's disease

Swerdlow, R. H., & Kish, S. J. (2002) · International review of neurobiology

Alzheimer's disease research and treatmentsMitochondrial Function and Pathology

Cited by 126

Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia

Furukawa, Y., Nygaard, T. G., Gütlich, M., Rajput, A. H., Pifl, C., DiStefano, L., Chang, L. J., Price, K., Shimadzu, M., Hornykiewicz, O., et al. (1999) · Neurology

Metabolism and Genetic DisordersNeurological diseases and metabolism

Cited by 117

Increased Vesicular Monoamine Transporter Binding during Early Abstinence In Human Methamphetamine Users: Is VMAT2 a Stable Dopamine Neuron Biomarker?

Boileau, I., Rusjan, P., Houle, S., Wilkins, D., Tong, J., Selby, P., Guttman, M., Saint-Cyr, J. A., Wilson, A. A., & Kish, S. J. (2008) · The Journal of Neuroscience

Neurotransmitter Receptor Influence on BehaviorParkinson's Disease Mechanisms and Treatments

Cited by 100

Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB.

Boileau, I., Mansouri, E., Williams, B., Le Foll, B., Rusjan, P., Mizrahi, R., Tyndale, R. F., Huestis, M. A., Payer, D. E., Wilson, A. A., et al. (2016) · Biological Psychiatry

Cannabis and Cannabinoid ResearchForensic Toxicology and Drug Analysis

Cited by 82

Do Glutathione Levels Decline in Aging Human Brain?

Tong, J., Fitzmaurice, P. S., Moszczynska, A., Mattina, K., Ang, L.-C., Boileau, I., Furukawa, Y., Sailasuta, N., & Kish, S. J. (2016) · Free Radical Biology and Medicine

Sulfur Compounds in BiologyAntioxidant Activity and Oxidative Stress

Cited by 47

Impacts of Canada's cannabis legalization on police‐reported crime among youth: early evidence

Callaghan, R. C., Vander Heiden, J., Sanches, M., Asbridge, M., Hathaway, A., & Kish, S. J. (2021) · Addiction

Crime Patterns and InterventionsCriminal Law and Policy

Cited by 44

Associations Between Canada's Cannabis Legalization and Emergency Department Presentations for Transient Cannabis-Induced Psychosis and Schizophrenia Conditions: Ontario and Alberta, 2015–2019

Callaghan, R. C., Sanches, M., Murray, R. M., Konefal, S., Maloney-Hall, B., & Kish, S. J. (2022) · The Canadian Journal of Psychiatry

Cannabis and Cannabinoid ResearchSchizophrenia research and treatment

Cited by 41

Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia

Furukawa, Y., Kapatos, G., Haycock, J. W., Worsley, J., Wong, H., Kish, S. J., & Nygaard, T. G. (2002) · Annals of Neurology

Metabolism and Genetic DisordersNeurological diseases and metabolism

Cited by 38

Canada’s cannabis legalization and drivers’ traffic-injury presentations to emergency departments in Ontario and Alberta, 2015-2019

Callaghan, R. C., Sanches, M., Vander Heiden, J., Asbridge, M., Stockwell, T., Macdonald, S., Peterman, B. H., & Kish, S. J. (2021) · Drug and Alcohol Dependence

Traffic and Road SafetyCannabis and Cannabinoid Research

Cited by 37

Corticotropin-releasing hormone and dopamine release in healthy individuals

Payer, D., Williams, B., Mansouri, E., Stevanovski, S., Nakajima, S., Le Foll, B., Kish, S., Houle, S., Mizrahi, R., George, S. R., et al. (2017) · Psychoneuroendocrinology

Stress Responses and CortisolNeurotransmitter Receptor Influence on Behavior

Cited by 26